Piper Sandler cuts Myriad Genetics stock to Underweight, citing doubts about the genetic testing company’s path to ...

Impressive results came out on drugs from Amgen, Arrowhead Pharmaceuticals, and Crispr Therapeutics. Their shares are all ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

This biotech innovator could be in only the early chapters of its success story.

Biotech stocks returned up to 36% in 2025, while longevity investing hit $8.5B in funding. Here’s the data individual ...

In this article, we will take a look at the 10 Most Profitable Biotech Stocks to Buy Now. Following a turbulent year for the markets in general and biotech in particular, the industry made a notable ...

Positive readouts in cancer and cardiac drug trials could keep the rally going. Sizing up the stakes for Merck, Moderna, Summit Therapeutics, and more.

Gaps are information. They are the place on the chart where you can see buyers and sellers jumping ahead to a fast repricing, ...

Legend Biotech has frequently been at the center of takeover rumors, and the stock regularly spikes on speculation that it has received formal buyout bids. It stands out as one of the most uniquely ...

Vir Biotechnology focuses on innovative immunology therapies for serious infectious diseases, offering potential in a high-stakes biotech landscape. As a U.S.-listed player, it matters to global ...